[1] Taylor DP, Wells JZ, Savol A, et al. Modeling boundary conditions for balanced proliferation in metastatic latency[J]. Clin Cancer Res, 2013, 19(5): 1063-1070.
[2] Páez D, Labonte MJ, Bohanes P, et al. Cancer dormancy: a model of early dissemination and late cancer recurrence[J]. Clin Cancer Res, 2012, 18(3): 645-653.
[3] Marsden CG, Wright MJ, Carrier L, et al. A novel in vivo model for the study of human breast cancer metastasis using primary breast tumorinitiating cells from patient biopsies[J]. BMC Cancer, 2012, 12: 10.
[4] Bellovin DI, Das B, Felsher DW. Tumor dormancy, oncogene addiction, cellular senescence, and selfrenewal programs[J]. Adv Exp Med Biol, 2013, 734: 91-107.
[5] Wu S, Lao XY, Sun TT, et al. Knockdown of ZFX inhibits gastric cancer cell growth in vitro and in vivo via downregulating the ERKMAPK pathway[J]. Cancer Lett, 2013, 337(2): 293-300.
[6] Lu Z, Luo RZ, Lu Y, et al. The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells[J]. J Clin Invest, 2008, 118(12): 3917-3929.
[7] Chen H, Ko JM, Wong VC, et al. LTBP2 confers pleiotropic suppression and promotes dormancy in a growth factor permissive microenvironment in nasopharyngeal carcinoma[J]. Cancer Lett, 2012, 325(1): 89-98.
[8] Almog N, Ma L, Schwager C, et al. Consensus microRNAs governing the switch of dormant tumors to the fastgrowing angiogenic phenotype[J]. PLoS One, 2012, 7(8): e44001.
[9] Wikman H, Vessella R, Pantel K. Cancer micrometastasis and tumour dormancy[J]. APMIS, 2008, 116(7-8): 754-770.
[10] Hurst RE, Hauser PJ, Kyker KD, et al. Suppression and activation of the malignant phenotype by extracellular matrix in xenograft models of bladder cancer: a model for tumor cell "Dormancy"[J]. PLoS One, 2013, 8(5): e64181.
[11] 王杰玉, 冯炜炜. 三维培养模型在肿瘤研究中的应用[J]. 国际肿瘤学杂志, 2013, 40(9): 659-661.
[12] Indraccolo S, Minuzzo S, Masiero M, et al. Crosstalk between tumor and endothelial cells involving the Notch3Dll4 interaction marks escape from tumor dormancy[J]. Cancer Res, 2009, 69(4): 1314-1323.
[13] Havard M, Dautry F, Tchénio T. A dormant state modulated by osmotic pressure controls clonogenicity of prostate cancer cells[J]. J Biol Chem, 2011, 286(51): 44177-44186.
[14] Lyu T, Jia N, Wang J, et al. Expression and epigenetic regulation of angiogenesisrelated factors during dormancy and recurrent growth of ovarian carcinoma[J]. Epigenetics, 2013, 8(12): 1330-1346.
[15] Marlow R, Honeth G, Lombardi S, et al. A novel model of dormancy for bone metastatic breast cancer cells[J]. Cancer Res, 2013, 73(23): 6886-6899.
[16] Barkan D, Green JE. An in vitro system to study tumor dormancy and the switch to metastatic growth.[J]. J Vis Exp, 2011, (54): 2914.
[17] Godugu C, Patel AR, Desai U, et al. AlgiMatrix(TM) based 3D cell culture system as an invitro tumor model for anticancer studies[J]. PLoS One, 2013, 8(1): e53708.
[18] Nardella C, Clohessy JG, Alimonti A, et al. Prosenescence therapy for cancer treatment[J]. Nat Rev Cancer, 2011, 11(7): 503-511. |